Page 69 - Read Online

Rosenzweig et al. J Cancer Metastasis Treat 2022;8:46 https://dx.doi.org/10.20517/2394-4722.2022.58 Page 7 of 9

yield the advances pancreatic cancer patients desperately need and deserve.

DECLARATIONS
Acknowledgments
The authors wish to acknowledge and thank all pancreatic cancer patients who contribute to clinical
research and provide hope to those patients of the future.

Authors’ contributions
Contributed to the writing: Rosenzweig A, Matrisian LM
Contributed to the review of this manuscript: Rosenzweig A, Moravek C, Matrisian LM

Availability of data and materials
Not applicable.

Financial support and sponsorship
This work was supported by the Pancreatic Cancer Action Network.

Conflicts of interest
All authors are employees of the Pancreatic Cancer Action Network and have no personal conflicts of
interest with any commercial interests mentioned in this publication. The Pancreatic Cancer Action
Network has received donations from the following companies over the past 2 years: AbbVie, Amgen
Foundation, AstraZeneca Pharmaceuticals, Boston Scientific, Bristol-Myers Squibb, Corcept, Covance,
Elevation Oncology, Eli Lilly, Fibrogen, Fujifilm Pharmaceuticals USA, Genentech, GlaxoSmithKline,
GRAIL, Immunovia, Ipsen Biopharmaceuticals, Johnson & Johnson, Merck Sharpe & Dohme Corp, Mirati
Therapeutics, Novocure, Novartis Pharmaceuticals, Pfizer, Rafael Pharmaceuticals, Servier Pharmaceuticals,
Takeda Pharmaceuticals NA, Tempus Health, TriSalus Life Sciences, Tyme, View Ray. Berry Consultants
are vendors for the Precision Promise clinical trial.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2022.

REFERENCES
1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin 2021;71:209-49. DOI PubMed
2. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin 2021;71:7-33. DOI
3. Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated projection of US cancer incidence and death to 2040. JAMA Netw Open
2021;4:e214708. DOI PubMed PMC
4. Nevala-Plagemann C, Hidalgo M, Garrido-Laguna I. From state-of-the-art treatments to novel therapies for advanced-stage pancreatic
cancer. Nat Rev Clin Oncol 2020;17:108-23. DOI PubMed
5. Hoos WA, James PM, Rahib L, Talley AW, Fleshman JM, Matrisian LM. Pancreatic cancer clinical trials and accrual in the United
States. J Clin Oncol 2013;31:3432-8. DOI PubMed
6. Rahib L, Fleshman JM, Matrisian LM, Berlin JD. Evaluation of pancreatic cancer clinical trials and benchmarks for clinically
meaningful future trials: a systematic review. JAMA Oncol 2016;2:1209-16. DOI PubMed
7. Matrisian LM, Berlin JD. The past, present, and future of pancreatic cancer clinical trials. Am Soc Clin Oncol Educ Book